Clin2
NCT07176949Possibly a fitRecruiting

Early myopia prevention study for young children

MyopiaPre-myopia

Treatments studied

Part of Eyes & vision clinical trials.

This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
508 people
Ages
3 years to 6 years
Study type
Interventional

Who can take part

  • Your child is between 3 and 6 years old.
  • Your child has mild nearsightedness or farsightedness (within a certain range after eye drops are used).
  • Your child does not have other eye problems like crossed eyes (strabismus), lazy eye (amblyopia), or cataracts.
  • Your child has not used special contact lenses, atropine eye drops, or other myopia treatments in the last 4 weeks.
  • Your child can understand instructions and cooperate to wear glasses as needed.
  • You (as a guardian) can agree to regular check-ups and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07765550Not yet recruiting
Special glasses to prevent nearsightedness in young children

This trial tests whether special glasses with small lens segments can help prevent nearsightedness in young children who are at higher risk. Taking part may help keep your child's vision from getting worse as they grow.

Shanghai, Shanghai Municipality
NCT07449247Not yet recruiting· Phase 1/Phase 2
Atropine eye drops for preventing nearsightedness in children

This study tests whether low-dose atropine eye drops can prevent nearsightedness (myopia) in children. Atropine is a medicine that has been used to slow myopia, and this trial looks at gradually increasing the dose to find the best approach.

NCT07863713Not yet recruiting· Phase 2
Early treatment plan for children at risk of nearsightedness

This study tests an early intervention for 5-6 year old children who are at risk of developing nearsightedness (myopia). The goal is to see if starting treatment early can prevent or slow down vision problems, which might help your child avoid stronger glasses later.

NCT06523504Recruiting· Phase 1/Phase 2
Atropine Drops with Special Glasses for Myopia in Children

This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.

Tianjin, Tianjin Municipality
NCT06765603Not yet recruiting· Phase 2
Contact lens and atropine for slowing myopia in children

This study tests whether combining a special contact lens with atropine eye drops can slow down the progression of nearsightedness (myopia) in children. It aims to find a more effective way to prevent their vision from getting worse.

NCT07567040Recruiting· Phase 3
Delaying Nearsightedness Onset in Children

This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.

Birmingham, Alabama

Hear when a new Myopia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.